Insider Trading & Ownership - Miller Mary

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Miller Mary
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-02-16
Sale
2022-02-17
5:21 pm
Butterfly Network Inc.BFLYMiller Mary
General Counsel & Corp Sec
16,677$5.9515$99,253139,068
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-11-27
6:11 pm
N/A
2034-02-28
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
67,567$067,567
(Direct)
View
2024-11-14
Tax Withholding
2024-11-18
4:31 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
184$7.9237,941
(Direct)
View
2024-10-17
Tax Withholding
2024-10-21
4:22 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
558$7.8738,125
(Direct)
View
2024-10-01
Tax Withholding
2024-10-03
6:49 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
284$6.9838,683
(Direct)
View
2024-08-14
Tax Withholding
2024-08-16
4:52 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
184$7.0238,967
(Direct)
View
2024-07-17
Tax Withholding
2024-07-19
4:20 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
558$7.6939,151
(Direct)
View
2024-05-14
Tax Withholding
2024-05-16
7:03 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
184$8.3639,709
(Direct)
View
2024-04-17
Tax Withholding
2024-04-19
4:10 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
558$10.3439,893
(Direct)
View
2024-02-14
Tax Withholding
2024-02-16
5:14 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
217$3.440,451
(Direct)
View
2024-01-17
Tax Withholding
2024-01-19
4:24 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
652$4.3540,668
(Direct)
View
2023-11-14
Tax Withholding
2023-11-16
7:43 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
735$5.0841,320
(Direct)
View
2023-10-17
Tax Withholding
2023-10-19
7:45 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
2,232$5.4842,055
(Direct)
View
2023-09-26
Option Award
2023-09-28
7:17 pm
N/A
2033-09-25
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
15,434$055,863
(Direct)
View

Ownership
2023-09-28
7:13 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVMiller Mary
Chief Legal Officer
0$0161,715
(Direct)
View
2022-03-22
Option Award
2022-03-24
5:12 pm
N/A
N/A
Butterfly Network Inc.BFLYMiller Mary
General Counsel & Corp Sec
54,789$0383,512
(Direct)
View
2022-03-04
Option Award
2022-03-08
4:59 pm
N/A
N/A
Butterfly Network Inc.BFLYMiller Mary
General Counsel & Corp Sec
189,655$0328,723
(Direct)
View
2021-02-12
Option Award(A)
2021-02-25
4:05 pm
N/A
2030-12-17
Butterfly Network Inc.BFLYMiller Mary
GC and CS
415,320$0415,320
(Direct)
View
2021-02-12
Option Award
2021-02-16
9:04 pm
N/A
2030-12-17
Butterfly Network Inc.BFLYMiller Mary
GC and CS
259,575$0259,575
(Direct)
View
(A) Indicate amendment filing.